Information
News News
- News Release
Elix Provides AI Drug Discovery Platform “Elix Discovery™” to Eisai
- Information
Article on the Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in Nikkei Biotech ONLINE and AnswersNews
- News Release
Elix and LINC Become the First in the World to Commercialize an AI Drug Discovery Platform Incorporating Federated Learning-Based AI Models Trained on Data from 16 Pharmaceutical Companies
The only platform that provides the tools needed for AI drug discovery,
from predictive and generative models with an intuitive GUI to expert consulting, all in a single package.
Proposing Structures Beyond Human Imagination
Rather than only accelerating what medicinal chemists can already do, we go further by proposing novel structures that they might not conceive. Our technology has demonstrated its value through multiple success stories.
Consulting & Support
Simply introducing AI products often does not ensure that chemists will become proficient in their use—a detail many AI companies overlook. At Elix, we offer comprehensive consulting and support from experienced researchers.
Openness & Sharing Knowledge
Unlike other AI companies, we are not secretive. We share our methods and knowledge transparently. This enables richer discussions and higher success in collaborative research.
Partners
Our Clients and Partners
We are collaborating with pharmaceutical companies, academic institutes, and drug discovery start-ups.
